203 related articles for article (PubMed ID: 6872479)
1. [Immunosuppressive therapy of chronic active hepatitis: results of a long-term follow-up].
Musca A; Cordova C; Barnaba V; Levrero M; Zaccari C; Trinchieri F; Gnecchi M
Clin Ter; 1983 Jun; 105(5):403-9. PubMed ID: 6872479
[No Abstract] [Full Text] [Related]
2. [Favorable outcome in chronic active hepatitis caused by B virus in childhood].
Cadrobbi P; Bortolotti F; Crivellaro C; Rugge M; Armigliato M; Realdi G; Bertaggia A
Minerva Pediatr; 1984 Jul; 36(13-14):685-9. PubMed ID: 6503897
[No Abstract] [Full Text] [Related]
3. [Long-term follow-up of hepatitis B virus infected patients after orthotopic liver transplantation].
Theilmann L; Arnold JC
Z Gastroenterol; 1995 Oct; 33(10):626-7. PubMed ID: 7502560
[No Abstract] [Full Text] [Related]
4. [Immunosuppressive therapy in patients with HBeAg-positive chronic active hepatitis B?].
Maier KP; Lepiorz H; Berthold H; Gerok W
Leber Magen Darm; 1982 Aug; 12(4):150-3. PubMed ID: 7132529
[TBL] [Abstract][Full Text] [Related]
5. Effect of immunosuppressive therapy on HBsAg-positive chronic active hepatitis in relation to presence or absence of HBeAg and anti-HBe.
Sagnelli E; Piccinino F; Manzillo G; Felaco FM; Filippini P; Maio G; Pasquale G; Izzo CM
Hepatology; 1983; 3(5):690-5. PubMed ID: 6618436
[TBL] [Abstract][Full Text] [Related]
6. [Chronic hepatitis B. Immunohistochemical demonstration and distribution of hepatitis B surface and core antigens].
Feiden W; Borchard F
Pathologe; 1985 May; 6(3):119-25. PubMed ID: 3892525
[No Abstract] [Full Text] [Related]
7. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B.
Scullard GH; Smith CI; Merigan TC; Robinson WS; Gregory PB
Gastroenterology; 1981 Dec; 81(6):987-91. PubMed ID: 7286593
[TBL] [Abstract][Full Text] [Related]
8. [Experience with immunosuppressive therapy of active chronic hepatitis using long-term multiple corticoids].
Tremolada F; Realdi G; Noventa F; Antona C; Ruol A
Clin Ter; 1985 Jan; 112(2):121-30. PubMed ID: 4017455
[No Abstract] [Full Text] [Related]
9. Immunosuppressive therapy in chronic liver disease.
Sherlock S
Minerva Med; 1978 Aug; 69(38):2605-9. PubMed ID: 714260
[TBL] [Abstract][Full Text] [Related]
10. [Should chronic active viral hepatitis be treated with drugs or not?].
Schalm SW
Internist (Berl); 1981 Dec; 22(12):717-20. PubMed ID: 7033161
[No Abstract] [Full Text] [Related]
11. Therapy of HBsAg-negative chronic active hepatitis in transfusion-dependent thalassemia major.
De Virgiliis S; Argiolu F; Rais M; Cossu P; Toccafondi C; Sanna G; Cornacchia G; Nucaro A; Ferreli A; Cao A
Birth Defects Orig Artic Ser; 1982; 18(7):355-60. PubMed ID: 6819018
[No Abstract] [Full Text] [Related]
12. [Hepatitis B: serological strategy and epidemiological aspects].
Penna R; Rabagliati AM
G Batteriol Virol Immunol; 1981; 74(1-6):145-62. PubMed ID: 7030851
[No Abstract] [Full Text] [Related]
13. [Comparative study of the "e" system (HBeAG/anti-HBeAg) and core antibodies in aggressive chronic hepatitis and liver cirrhosis].
Marinucci G; Muglia M; Di Giacomo C; Petrucci L; Mancini R; Costa F; Bachetoni A
Quad Sclavo Diagn; 1981 Mar; 17(1):81-5. PubMed ID: 7313073
[No Abstract] [Full Text] [Related]
14. HBeAg/anti-HBe seroconversion during and after protracted immunosuppressive treatment in type B chronic hepatitis.
Tanno H; Fay OH; Rojman JA; Palazzi J; Bessone F
J Med Virol; 1988 May; 25(1):45-51. PubMed ID: 3045258
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of chronic active hepatitis (HBsAg +,HBeAg +) with isoprinosine. Clinical evaluation].
Cianciara J; Loch T; Babiuch L; Dabrowska-Bernstein B; Stasiak A; Dabrowski M; Pawińska A
Pol Tyg Lek; 1988 Sep; 43(37):1195-8. PubMed ID: 2470069
[No Abstract] [Full Text] [Related]
16. Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.
Kelly TJ; Sanchez TV; Patterson MJ; Mayor GH
Proc Clin Dial Transplant Forum; 1980; 10():165-8. PubMed ID: 7346842
[No Abstract] [Full Text] [Related]
17. Azathioprine treatment in a patient with HBsAg-positive acute viral hepatitis complicated by bridging necrosis.
Sagnelli E; Felaco FM; Pasquale G; Filippini P; Piccinino F
Infection; 1983; 11(1):31-2. PubMed ID: 6840865
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival in living related donor renal allograft recipients with hepatitis B infection.
Roy DM; Thomas PP; Dakshinamurthy KV; Jacob CK; Shastry JC
Transplantation; 1994 Jul; 58(1):118-9. PubMed ID: 8036701
[No Abstract] [Full Text] [Related]
19. [New knowledge on persistent and latent hepatitis B virus infections].
Baumgarten R
Z Arztl Fortbild (Jena); 1987; 81(18):931-2. PubMed ID: 3424877
[No Abstract] [Full Text] [Related]
20. Methyl-prednisolone treatment of serum HBsAg negative chronic active hepatitis occurring in transfusion-dependent thalassemia major.
De Virgiliis S; Argiolu F; Rais M; Cossu P; Toccafondi C; Sanna G; Cornacchia G; Nucaro A; Bertolino F; Ferreli A
Helv Paediatr Acta; 1983 Aug; 38(3):255-65. PubMed ID: 6618892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
